jhmi.edu Objective Although pancreatic ductal adenocarcinoma is considered a rapidly progressive disease, mathematical models estimate that it takes many years for an initiating pancreatic cancer cell ...

1Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. *Corresponding Author: John Paul Shen, Department of Colon and Rectal Surgery, The ...

1Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, P. R. China. 2Jiangsu Key Laboratory ...

Impact of baseline alterations in HER2-pathway oncogenic drivers on response to anti-HER2 therapy in patients (pts) with HER2-amplified advanced colorectal cancer (aCRC). This is an ASCO Meeting ...

AI decision support system non-homogenously influences clinical decisions in dynamic treatment regimen, as it depends on several factors including prior knowledge, preference, disease type ...

Background: Colon adenocarcinoma (COAD) is a highly heterogeneous disease ... which included the large intestine, colon, appendix, cecum, and rectum. Grade consists of four categories: well ...

non-proven adenocarcinoma, signet ring cell type, recurrent or metachronous cancer. In addition, cancer that occurred in the colon, starting from the cecum to the splenic flexure colon, was defined as ...

Colonoscopy confirmed the presence of a mass in the cecum that was biopsied positive for an adenocarcinoma. Liver biopsy was consistent with metastatic adenocarcinoma of the colon. The patient had ...